You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
畢馬威:中國民衆對康復醫學認識有待提高 料相關市場將迎來快速發展
畢馬威發佈《中國社會辦康復醫療50企業報告》,發現入榜醫院中,江浙兩省總康復牀位佔半壁江山,另外,入榜醫院存在衛生技術人員整體配備不足,康復人才短缺現象,不同梯隊醫院在信息化、人才和品牌建設方面存在較大差距。 報告指出,領軍康護服務機構獎中,在15家入榜機構佈局的全部業態中,入局者最青睞康復醫院、康復診所和護理院。其中,佈局康復專科醫院的佔比最高,高達29%,康復診所佔比17%,護理院佔比16%。 畢馬威中國華東及華西區醫療健康行業主管合夥人謝旺培表示,目前民衆對康復醫學的認識還有待提高,固有觀念中「重臨牀、輕康復」的意識使康復醫學沒有被充分認識,從而無法得到有效地利用。但在人口快速老齡化和慢性病人羣增加的趨勢下,全民康復意識的培養已迫在眉睫。 此外,畢馬威中國副主席吳國強認爲,「十四五」時期是醫療衛生健康高質量發展的關鍵時期,相信在政策紅利、人口老齡化、康復觀念普及等多種因素的推進下,中國康復事業將迎來快速發展,並惠及更多的民衆。而與臨牀醫學相比,中國康復醫學起步較晚,康復醫療資源配置匱乏、醫療能力薄弱。在人口老齡化加劇、慢病人羣不斷增長,以及民衆健康消費持續升級的背景下,近年來康復醫療供需缺口明顯擴大。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account